Navigation Links
RoosterBio Will Attend Society for Biomaterials Annual Meeting April 3-6, 2019
Date:3/29/2019

RoosterBio, Inc, a leading supplier of innovative human Mesenchymal Stem/Stromal Cell (hMSC) biomanufacturing systems, will attend the Society for Biomaterials Annual Meeting & Exposition on April 3-6, 2019 in Seattle, Washington.

“This conference gives us the opportunity to connect with academic, healthcare, governmental and business professionals in all aspects of the biomaterial science field who are advancing the rapidly growing regenerative medicine industry,” said RoosterBio CEO Margot Connor. “RoosterBio’s products are accelerating the cell-based bioeconomy by providing standardized hMSCs product platforms that enable rapid clinical and commercial translation. By sharing knowledge at the annual meeting, we can collaborate across various scientific disciplines including materials science, biology, engineering and medicine to improve human health.”

RoosterBio Scientist Josephine Lembong, PhD will present a poster at the conference titled, ‘Scalable Xeno-Free Microcarrier-based Suspension Bioreactor System for Biomanufacturing of Human Mesenchymal Stem/Stromal Cells (hMSCs) for Regenerative Medicine’ (#1067). Poster Sessions will be held on Thursday, April 4, 2019 from 6:30pm to 8:00pm and Friday, April 5, 2019 from 3:45pm to 5:15pm.

Commenting on the poster, Connor added, “The data shown in this presentation demonstrates our robust, scalable hMSC culture process in bioreactors. The consistent cell yield and maintained cell quality exhibited with this scalable fed-batch process allows the adaptation of this plug-and-play standardized system by translational researchers and hMSC product developers in the regenerative medicine, tissue engineering, and cell therapy fields, while providing significant time and cost savings.”

Additional meeting details can be located on the conference website at http://www.2019.biomaterials.org.

About RoosterBio, Inc
RoosterBio, Inc. is a privately held cell manufacturing platform technology company focused on accelerating the development of a sustainable regenerative medicine industry, one customer at a time. RoosterBio's products are high-volume, affordable, and well-characterized adult human mesenchymal stem/stromal cells (hMSCs) paired with highly engineered media systems. RoosterBio has simplified and standardized how stem cells are purchased, expanded, and used in development, leading to marked time and costs savings for customers. RoosterBio's innovative products are ushering in a new era of productivity and standardization into the field, accelerating the road to discovery in Regenerative Medicine. For more information on RoosterBio, please visit http://www.roosterbio.com.

Read the full story at https://www.prweb.com/releases/roosterbio_will_attend_society_for_biomaterials_annual_meeting_april_3_6_2019/prweb16204466.htm.


'/>"/>
Source: PRWeb
Copyright©2019 Vocus, Inc.
All rights reserved


Related biology news :

1. RoosterBio Announces Plans to Expand Facility in Frederick, MD
2. RoosterBio Inc. and Tissue Regeneration Therapeutics Inc. Announce Alliance Around Scale-up Manufacturing of Umbilical Cord Tissue Perivascular Cell Technology
3. RoosterBio, Inc. Earns NIIMBL Nod with 2 Grant Awards for Regenerative Medicine Manufacturing
4. Pharmica Consulting to Attend 10th Annual SCOPE Summit in Orlando, Florida
5. JoVE Awards Travel Grants To Gobal Contest Winners To Attend Prestigious Charleston Library Conference
6. Too Busy to Travel? Attend a Virtual Healthcare Career Fair from Home or Office
7. Perkotek Adds Fingerprint Devices to Attendance Control Systems
8. Montparnasse Pasteleria Achieves Time and Attendance Transparency with Crossmatch U.are.U Fingerprint Readers
9. Neurotechnology Releases Latest Update to NCheck Biometric Time and Attendance Software
10. 5 Nobel Laureates attending EuroScience Open Forum in Copenhagen
11. Attend the Gut Microbiota for Health World Summit 2014
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/4/2019)... (PRWEB) , ... June 04, 2019 , ... ... today announced the appointment of Susan Murphy as the new President of Molecular ... Sciences?owned by Molecular Devices’ parent company, Danaher Corporation. , Since joining Molecular Devices ...
(Date:6/4/2019)... TORONTO (PRWEB) , ... June 04, 2019 , ... ... automate the search for salient features of seizure risk signals, usually based on ... neurologist-driven EEG interpretation remains the only acceptable diagnostic methodology due to the complexity ...
(Date:6/3/2019)... (PRWEB) , ... June 03, 2019 , ... Stay on ... biotech, medical device and food industries. Access to all webinars is free, so be ... relevant in your field! , Visit http://www.xtalks.com to see our upcoming webinars: ...
Breaking Biology News(10 mins):
(Date:5/21/2019)... ... May 21, 2019 , ... DuPont Nutrition & ... the inaugural Africa Brewing Conference dedicated to sharing brewing knowledge, strengthening relationships and ... which is supported through a partnership with “Ethiopia Invest”, will run through May ...
(Date:5/14/2019)... ... 14, 2019 , ... Gateway Genomics , a leading developer of prenatal ... to 5,000 square feet. , “This past year has seen exponential growth for ... CEO, Chris Jacob. “The SneakPeek At-Home test, which is mailed directly to our customers ...
(Date:5/4/2019)... ... May 03, 2019 , ... Diopsys ... Diopsys® ffERG/Photopic Negative Response vision test, a new full field electroretinography ... is estimated that 6.3 million Americans will have glaucoma, with black Americans having ...
(Date:5/2/2019)... ... May 02, 2019 , ... Researchers from Ambry ... discrepancies between U.S. insurer policies for genetic testing and the 2019 National Comprehensive ... and ovarian cancer (HBOC). , Jill S. Dolinsky, director of clinical ...
Breaking Biology Technology: